Nardin is a co-founder and CTO at Simmunome, where she combines her knowledge in engineering, machine learning, and neuroscience.
After gaining experience as a regional electrical engineer at Proctor and Gamble, Nardin's passion for research drew her back to academia. This led her to pursue a Ph.D. in Neuroscience at McGill University, where she utilized machine learning and diverse modeling techniques to investigate the brain's information processing and learning capabilities.
As CTO of Simmunome, Nardin leads the company's research and development efforts, focusing on innovative AI models that simulate disease pathways and predict drug efficacy outcomes.